Over the past 2 decades, eosinophilic esophagitis (EoE) has transformed from a case-reportable disease to a substantial cause of upper gastrointestinal morbidity. 1 The reasons for this increase are likely multifactorial, including increased disease recognition and changing environmental factors, particularly those interacting with immunologic pathways involved in patients with EoE. 2, 3 Numerous genetic susceptibility variants have been shown to contribute to EoE, including variants at 5q22 (TSLP/ WDR36), 2p23 (CAPN14), and 11q13 (LRCC32), but the magnitude of association for disease susceptibility is modest (<2-fold), similar to the magnitude seen in other allergic and immunologic diseases. Twin studies have established a role for genetics in disease susceptibility but an even stronger role for environmental factors, particularly those encountered in early life, as shown by the marked increased concordance for EoE between dizygotic twins compared with nontwin siblings and environmental assessments in EoE case-control studies. 4, 5 Identification of gene-environment interactions for EoE offers an opportunity to improve understanding of the mechanisms for disease development. It also might offer a means for identifying possible modifiable risk factors for disease, specifically risk factors that might only be relevant in the presence of specific genetic susceptibility variants. Therefore, we conducted a preliminary case-control study of gene-environment interaction between EoE genetic variants [6] [7] [8] [9] and early-life exposures that have been associated with EoE and other atopic diseases (see Table E1 in this article's Online Repository at www.jacionline. org).
5,10-12 Specifically, we examined interaction between 5 6-9 CAPN14 encodes an IL-13-induced, calcium-activated cysteine protease involved in maintaining integrity of esophageal barrier function and is overexpressed in patients with EoE. 13, 14 The rs4329885 SNP, which is found on the 15q13 chromosome band between LOC283710 and KLF13, is in a region that is influential for gene regulation, might contribute to the impaired esophageal epithelial cell development that has been observed to occur in patients with EoE, 15 and has been shown to be involved in T H 2 cytokine production. 16 TSLP, a gene that is critical to inducing allergen sensitization, is strongly associated with and overexpressed in patients with EoE. 9, 17 CCL26 encodes for eotaxin-3, the most upregulated gene in patients with EoE, and acts as a chemoattractant for the activation and recruitment of eosinophils into esophageal tissue.
8 TGF-b secretion, which is produced in part by eosinophils, is implicated in the fibrosis of esophageal tissue observed in patients with EoE, as well as in immunomodulation. 18 Although the exact mechanism for a possible interaction is unknown, it might be that environmental factors have epigenetic effects that influence DNA expression. 19, 20 
METHODS
Cases were recruited from the Cincinnati Center for Eosinophilic Disorders at Cincinnati Children's Hospital Medical Center and met the criteria for EoE diagnosis, as defined by current consensus guidelines. 21 Control subjects, which were used to assess violation of the assumption of independence between exposure and genotype in the noncases, were recruited from the Cincinnati Children's Hospital Medical Center Genomic Control Cohort, a population-based control cohort representative of the Greater Cincinnati population. 22 Cases and control subjects were restricted to those less than 18 years if age at the time of enrollment, and all were of self-reported white race.
Early-life environmental factor assessment
Early-life environmental factors for cases and control subjects were assessed through an online self-administered questionnaire provided to mothers. The questionnaire, which was described previously in detail, 10 was developed to study early-life exposures through an interactive process that included cognitive interviewing and testing. Survey domains included prenatal, intrapartum, and pediatric exposures, and the exposures of interest for this study were limited to those previously associated with EoE or demonstrating main effect associations in the current study population, 5 including cesarean delivery, preterm birth, admission to the NICU, formula feeding, and antibiotic use (see Table E1 ). 5, [10] [11] [12] 23 SNP genotyping and quality control DNA from cases and control subjects was obtained from peripheral blood samples. Cases and control subjects were genotyped with the genome-wide OMNI5 BeadChip array (Illumina, San Diego, Calif). 22 Examination of call rates identified less than 0.1% missing genotypes. We identified no evidence of departure from Hardy-Weinberg equilibrium in cases, control subjects, or cases and control subjects combined (see Table E2 in this article's Online Repository at www.jacionline.org). Before analyses, we performed principal components analysis with EIGENSOFT 24 on 639 ancestry informative markers from the OMNI5 BeadChip (Illumina). 22 
Statistical analyses
In our primary analysis, we conducted a case-only gene-environment interaction analysis. We used a generalized linear model (logit link and binomial distribution) to assess the association between each environmental factor and genotype in cases. We modeled the risk allele by using a recessive mode of inheritance if the risk allele was the major allele (eg, GG or GA vs GG) and a dominant mode of inheritance if the risk allele was the minor allele (eg, AA vs AG or GG). If there was marginal evidence of an interactive effect (P < .10) in the case-only analysis, we tested the assumption of independence between the exposure and genotype in the source population by modeling the association between exposure and genotype in the controls. Lack of independence was identified by evidence of a similar direction and magnitude of association between exposure and genotype in cases and control subjects.
In secondary analyses to facilitate interpretation of any interactive effect, we used cases and control subjects to estimate the odds of disease in those with the susceptibility genotype only, those with the environmental factor only, and those with both the susceptibility genotype and the environmental factor relative to those with neither the susceptibility genotype nor the environmental factor. Additionally, we modeled disease risk within those with the susceptibility genotype as a means for assessing the contribution of each early-life factor in those with the susceptibility genotype. For all models, we estimated both crude and adjusted (adjusted for maternal education and 2 principal components for ancestry) associations. The presence of interaction was determined by indication of a case-only interaction (P < .05) and indication of stratum-specific differences in the magnitude of association in the casecontrol assessment. Finally, we calculated the relative excess risk due to interaction (RERI) to assess for interaction on the additive scale. 25, 26 We generated both crude and adjusted estimates for both primary and secondary analyses. Adjusted models included adjustment for maternal education as a proxy for socioeconomic status and population stratification. The study was approved by the Cincinnati Children's Hospital Medical Center institutional review board.
RESULTS
Of the 237 patients successfully contacted, 169 (71%) consented to participate. Of these, 136 (80%) completed the questionnaire. Similarly, for control subjects, of the 208 potential subjects successfully contacted, 147 (71%) consented to participate, and of these, 125 (85%) completed the questionnaire. Our final analytic sample, after exclusion of observations with missing data, included 127 cases and 121 control subjects. The demographic features of the cases and control subjects were similar, with the exception of atopic disease comorbidities (eg, 83.3% cases vs 12.4% control subjects reporting food allergies) and sex (80.3% male subjects among cases vs 52.1% among control subjects, Table I ).
In our primary case-only analyses, we observed interaction between rs6736278 within CAPN14 and breast-feeding (P 5 .02, Fig 1) . We also observed interaction between rs17815905 in the LOC283710 and KLF13 region and NICU admission (P 5 .02). There was no evidence of a statistically significant interaction between the SNPs in CCL26, TSLP, or TGFB with any of the early-life factors examined (see Table E3 in this article's Online Repository at www.jacionline.org). Where there was evidence of interaction or marginal evidence of interaction (TSLP and NICU admission and TSLP and no furred pets in infancy), we found no evidence of violation of independence (see Table E4 in this article's Online Repository at www.jacionline.org). Secondary analyses confirmed the case-only interactions observed (Fig 2 and Tables II and III) , and stratum-specific assessments identified breast-feeding as a potentially modifiable factor in development of EoE among children with a certain CAPN14 genotype (Table II) . Notably, we observed a 92% reduction in the odds of having EoE among those who were breast-fed within the subgroup of participants harboring the susceptibility genotype (Table II) . Examination of interaction on the additive scale, RERI, identified a strong departure from additivity for CAPN14 and breast-feeding (RERI, 26.27; 95% CI, 217.27 to 4.72; Table II) and the LOC283710 and KLF13 region and NICU admission (RERI, 24.53; 95% CI, 210.81 to 1.76); however, neither of these reached statistical significance (Table III) .
DISCUSSION
In this study, we examined interaction between 5 gene variants (rs6736278 within CAPN14 at 2p23, rs2302009 within CCL26 at 7q11, rs3806932 within TSLP at 5q22, rs17815905 within the LOC283710 and KLF13 region at 15q13, and rs1800469 within TGFB at 19q13) and 6 maternally reported early-life exposures (cesarean delivery, preterm delivery, NICU admission, breast-feeding, antibiotics in infancy, and absence of a furry pet in infancy). We conducted case-only tests of interaction (with subsequent confirmation of results with the case-control analysis) and observed evidence of statistical interaction between rs6736278 (CAPN14) and breast-feeding and rs17815905 (LOC283710 and KLF13 region) and NICU admission. Case-control analyses of these associations provided additional evidence to support the presence of an interaction. The combined effect of susceptibility genotype and environmental exposure was less than expected (eg, antagonistic) after examining the independent effect of genotype and environmental exposure. For example, the combined effect for breast-feeding and genotype was significantly less (adjusted odds ratio [aOR], 0.43; 95% CI, 0.12-1.62) than the effect of genotype (aOR, 5.38; 95% CI, 0.89-32.71) or breast-feeding alone (aOR, 1.70; 95% CI, 0.76-3.77). Indeed, breast-feeding had a strong protective effect (aOR, 0.08; 95% CI, 0.01-0.59) in those with the susceptibility genotype (rs6736278 within CAPN14). Although the exact mechanism of how breast-feeding and CAPN14 can interact and become protective for disease is unknown, the protective effect of breast-feeding was demonstrated in a study of interaction between breast-feeding and the CD14 genotype (CD14C-159T) in relation to atopic sensitization. 27 CAPN14 is integral to maintaining barrier function in the esophagus. 13, 14 Potentially, with impaired barrier function, breast-feeding might confer a greater protective effect than that observed when barrier function is preserved; however, this must be investigated in follow-up mechanistic studies.
The early-life factors examined in this study have been associated with dysbiosis in gut colonization and early life. [28] [29] [30] [31] [32] [33] [34] [35] [36] Indeed, the esophagus harbors its own microbiome that is dysregulated in patients with EoE. 37 It is interesting to speculate that the interacting SNPs might mediate their effects by modifying esophageal microbiota content and/or their interaction with EoE-related immunologic pathways, even before EoE onset. 28, [38] [39] [40] Although this study was not designed to directly assess the influence of these exposures on the microbiome, the results provide the first potential evidence of gene-environment interactions in patients with EoE and support future work examining the microbiome and EoE.
Our results must be interpreted with caution because this preliminary study had a relatively small sample size, and we have not sought to replicate these findings in an independent sample. Furthermore, the associations reported required only nominal significance (P < .05) and did not account for multiple testing. To try to minimize the risk of false-positive results, we limited the analyses and environmental effects that had been associated with EoE risk in prior studies. Given that many of the exposures are correlated (eg, preterm delivery and NICU admission), each exposure-genotype interaction assessment did not represent a completely independent test, and the exposures and SNPs selected were selected a priori based on hypotheses of an interactive effect, as opposed to an agnostic study of gene-environment interaction in which multiple correction testing might be more relevant. 41 Although we observed interaction for several of the environmental exposures examined, these exposures might be a proxy for some other factor or factors that are interacting with the identified genes. Additionally, although early-life factors, such as cesarean delivery, breast-feeding, NICU admission, and having pets in the home, are likely not hampered by recall bias, recall of antibiotic use and possibly preterm delivery could be biased. In conclusion, we have preliminary evidence that the cause of EoE might involve the interplay of gene and environmental factors. Further understanding of these interactions provides an opportunity to potentially alter the development of EoE because environmental factors can be modified in subjects harboring specific genetic variants. Case-control analysis interaction plots for early-life factors and susceptibility genotype. Plots denote interaction between selected exposures and genotype variants in the case-control analyses. Interaction models include adjustment for maternal education. G1, Exposed to susceptibility genotype variant; G-, unexposed to susceptibility genotype variant. A, Difference in risk for those breast-fed and not breast-fed among those with the susceptibility genotype variant. B, Increase in risk for NICU admission and those without the susceptibility variant.
Clinical implications: EoE-predisposing polymorphisms interact with early-life factors to modify the risk of EoE disease development. The risk for EoE disease might be modifiable in subjects with certain environmental exposures and gene variants. OR, Odds ratio. *Twenty-one had missing data for characterizing antibiotic use in infancy. Assumption of independence tested (Table E4) . 
